Hints and tips:
Related Special Reports
...A top EU court has ruled that the name of the dead Colombian drug kingpin Pablo Escobar cannot be registered as a trademark in the EU....
...The ruling came after Escobar Inc, the company set up by his brother, filed an application in 2021 with the European Union Intellectual Property Office (EUIPO) for registration of the word sign Pablo Escobar...
...The company said the decision was partly driven by huge demand for weight-loss drugs....
...The company has genetically validated two other drug targets....
...Patients with terminal breast cancer in England will be denied access to a new treatment that has already been approved in Scotland, after a public health body said the drug did not provide value for money...
...Patients with terminal breast cancer in England will miss out on a new drug already approved in Scotland, after spending watchdog NICE said Enhertu, developed by Japanese pharma company Daiichi Sankyo and...
...insurers to cover the drug....
...It is now raising $600mn to launch its pioneering drug Rezdiffra in the US. Madrigal’s market value is about $5.1bn....
...Hong Kong-based activist fund Oasis Management has bought a 9.6 per cent stake in the company, which has a market value of $1.2bn....
...The company’s immunotherapy drug Imfinzi helped patients with so-called limited stage small cell lung cancer survive for longer....
...Drugs companies issued 1,643 warnings of impending shortages in 2023, compared to 648 in 2020, the research found....
...Scientists have invented a potential drug candidate that successfully combats antibiotic-resistant “superbugs” in non-human tests, according to research....
...Finding an effective treatment for Alzheimer’s has proved fiendishly difficult for drug companies, and previous regulatory decisions in the field have stirred controversy....
...Soaring sales of the products have pushed the companies’ valuations to record highs....
...The company plans to “move forward as quickly as possible” with further trials in MASH for the drug....
...In its 2023 financial report, the company said the value of its primate assets had fallen by about $40mn....
...The deal between Amazon Pharmacy and Eli Lilly, the world’s largest drugmaker by market value, will allow Amazon to dispense medicines including the pharma group’s popular weight-loss injection pen....
...But healthcare providers must also decide whether weight-loss drugs represent value for money....
...The latest estimate of the value of its music rights has given the company an NAV per share of 92p....
...Roche recently agreed to buy the company for up to $3bn. The plan is to combine its drugs with ones in the Swiss company’s pipeline, with a view to preserving muscle mass....
...However, Huffman has retained restricted stock units eligible to vest if Reddit attains an average $5bn market value for 10 consecutive days....
...help the UK company to develop a portfolio of radioconjugate drugs....
...Bobby Gaspar, co-founder and chief executive of Orchard, said Lenmeldy was “a paradigm-shifting medicine”, adding that the company was “committed to enabling broad, expedient and sustainable access to this...
...Instead, drugs companies will be on the hook for an uncapped 20 per cent share of catastrophic costs....
...Sales of cancer drugs helped AstraZeneca to beat City expectations in 2023, as the FTSE 100 company forecast continued double-digit sales growth in 2024....
International Edition